FDA Grants AP Status for OXYCET (ANDA087463) by SPECGX LLC
The FDA has granted Abbreviated Approval (AP) status for OXYCET, a combination of acetaminophen and oxycodone hydrochloride, submitted by SPECGX LLC.
Asset / Drug
Drug and asset intelligence for OXYCET with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.